INT2337

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.36
First Reported 1978
Last Reported 2010
Negated 0
Speculated 0
Reported most in Body
Documents 3
Total Number 4
Disease Relevance 1.10
Pain Relevance 0.20

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

extracellular region (PRB4) molecular_function (PRB4) biological_process (PRB4)
Anatomy Link Frequency
blood 1
PRB4 (Homo sapiens)
Pain Link Frequency Relevance Heat
cva 2 85.72 High High
Angina 2 82.72 Quite High
aspirin 4 5.00 Very Low Very Low Very Low
Potency 4 5.00 Very Low Very Low Very Low
cytokine 2 5.00 Very Low Very Low Very Low
Inflammation 2 5.00 Very Low Very Low Very Low
addiction 2 5.00 Very Low Very Low Very Low
IPN 2 5.00 Very Low Very Low Very Low
imagery 2 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Disease 2 98.40 Very High Very High Very High
Cancer 26 98.16 Very High Very High Very High
Fibrosarcoma 16 97.00 Very High Very High Very High
Hemorrhage 2 85.72 High High
Thrombosis 2 85.12 High High
Complex Regional Pain Syndromes 2 83.08 Quite High
Sarcoma 2 52.44 Quite High
Hypoxia 2 5.00 Very Low Very Low Very Low
Death 2 5.00 Very Low Very Low Very Low
INFLAMMATION 2 5.00 Very Low Very Low Very Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
We conclude that the decrease in arterial PO2 following sublingual nitroglycerin is caused by redistribution of pulmonary blood flow with imbalance in ventilation-perfusion relationships or shunting.
Negative_regulation (decrease) of PO2 in blood
1) Confidence 0.36 Published 1978 Journal Circulation Section Abstract Doc Link 411608 Disease Relevance 0.07 Pain Relevance 0.07
However, the arterial PO2 decreased from a mean of 80 +/- 3 (SEM) to 72 +/- 2 mm Hg (P less than 0.001) and mean venous admixture increased from 8.8 +/- 1% to 12.6 +/- 1.5% (P less than 0.001).
Negative_regulation (decreased) of PO2
2) Confidence 0.36 Published 1978 Journal Circulation Section Abstract Doc Link 411608 Disease Relevance 0.08 Pain Relevance 0.08
This decrease in cell viability upon PO treatment was also concentration dependent (Fig. 5A).
Negative_regulation (decrease) of PO
3) Confidence 0.10 Published 2010 Journal PLoS ONE Section Body Doc Link PMC2925949 Disease Relevance 0.53 Pain Relevance 0.04
Based on our study, PO appears to be a promising angiogenic inhibitor and applicable to angiogenesis related diseases.
Negative_regulation (inhibitor) of PO associated with disease
4) Confidence 0.08 Published 2010 Journal PLoS ONE Section Body Doc Link PMC2925949 Disease Relevance 0.42 Pain Relevance 0

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox